Fast forward to 3 months later. Has SRPT disclosed what was in the FDA meeting minutes?
I suspect the FDA gave Prosensa/GSK its view in late December or early January given GSK walked soon after.
When was RNA supposed to have re-met with regulators? Sounded like they were planning a followup after the Jan16th press release. Any thoughts on Drisa re-dosing? Curious if they have considered doing IV vs the current subq.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.